Key Takeaways
- The European Investment Bank is lending Limagrain EUR 300 million to accelerate R&D in plant genetics, described as one of the EIB's largest-ever financing operations in the European agricultural sector.
- The loan funds R&D led by Limagrain subsidiary Vilmorin and Cie, targeting yield, disease and pest resistance, drought tolerance, and nutritional and environmental crop qualities.
- The financing is structured through the EIB's TechEU programme and is backed by the European Commission's InvestEU guarantee.
- This is Limagrain's second EIB loan, following a EUR 170 million facility in 2020 focused on climate adaptation in seeds.
- Limagrain, the world's fourth-largest seed company, devoted EUR 324 million to R&D in 2024-2025.
Limagrain Secures EUR 300 Million EIB Loan to Accelerate Plant Genetics R&D
The European Investment Bank has agreed to lend French seed producer Limagrain EUR 300 million to expand research and development in plant genetics, in what the EIB describes as one of its largest-ever financing operations in the European agricultural sector. The loan funds activities led by Limagrain's subsidiary Vilmorin and Cie, targeting the development of more productive, resilient, and nutritionally improved crop varieties for farmers globally.
Research programs will address yield, disease and pest resistance, climate and regional adaptability, drought tolerance, and nutrient use efficiency, alongside nutritional and environmental crop quality improvements. The loan is structured through the EIB's TechEU programme and is backed by the European Commission's InvestEU guarantee.
“With this financing, we are supporting a strategic link in our food sovereignty,” said EIB Vice-President Ambroise Fayolle. “Innovating in plant genetics means giving farmers the means to face climate challenges by providing them with access to more resilient seeds. This project illustrates the ambition of our TechEU investment programme: strengthening Europe's capacity for innovation in key sectors such as agriculture and bioeconomy.”
Second EIB Facility for Limagrain as Seed Innovation Becomes a Policy Priority
This is Limagrain's second EIB loan, following a EUR 170 million facility in 2020 focused on climate adaptation in seeds. A French agricultural cooperative and the world's fourth-largest seed company, Limagrain devoted EUR 324 million to R&D in 2024-2025.
“The EUR 300 million financing provided by the EIB to Limagrain reflects a strong conviction: Europe must invest in its agricultural sovereignty and its capacity for innovation,” said Limagrain CEO Sebastien Chauffaut. “Investing in agriculture and in plant innovation ultimately means investing in the stability, security and balance of the world to come.”
EIB's Broader Agricultural Financing Commitment
The loan forms part of the EIB Group's EUR 3 billion pan-European package for agriculture and the bioeconomy launched at the end of 2024, intended to mobilize EUR 8.4 billion in total investment. In 2025, the EIB Group invested EUR 13 billion in France, including EUR 800 million in agriculture and the bioeconomy.
